MARKET OVERVIEW
The global healthcare fraud detection market reached an estimated USD 3.0 billion in 2024 and is projected to surge to USD 16.4 billion by 2033, growing at a robust 19.66% CAGR. This expansion is fueled by rising instances of insurance and pharmacy claims fraud, accelerating digitalization in healthcare, and ongoing adoption of AI/ML-powered, cloud-based detection solutions—offering more accurate, real-time insights.
STUDY ASSUMPTION YEARS:
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019–2024
- FORECAST YEAR: 2025–2033
HEALTHCARE FRAUD DETECTION MARKET KEY TAKEAWAYS
- Market Size & Growth: Valued at USD 3.0 B in 2024, expected to reach USD 16.4 B by 2033, with a 19.66% CAGR
- Regional Dominance: North America leads market share due to complex insurance systems and high digital healthcare spend
- Technology Segmentation: All analytics types—descriptive, predictive, and prescriptive—are widely adopted to detect and respond to fraud
- Delivery Modes: On‑premises retention is strong in compliance-focused institutions, while cloud/on‑demand grows for its scalability
- Application Use Cases: High demand for insurance claims review and payment integrity to prevent improper or fraudulent payouts
- End Users: Private insurers and government agencies are leading adopters, investing in AI‑driven fraud detection systems
MARKET GROWTH FACTORS
1. Technological Advancements in AI/ML
AI and machine learning are shaking things up in the world of fraud detection. They’re making it possible to monitor claims in real-time, spot anomalies, and recognize patterns like never before. By learning from past data, these technologies help cut down on false positives and boost accuracy. Plus, with biometric sensors being woven into fraud analytics, identity verification is getting a major upgrade, which helps tackle impersonation fraud. Take MediBuddy’s Sherlock, for example—this AI-driven claims screening tool, launched in August 2024, showcases the move towards next-gen, real-time fraud prevention, really pushing the market forward.
2. Regulatory Pressure and Digital Healthcare Adoption
On the regulatory front, governments and payers are under increasing pressure to maintain payment integrity and fight against fraudulent spending. The growth of digital health infrastructures—like EHRs, telemedicine, and cloud systems—has raised the stakes for fraud risk, but it’s also given organizations the tools they need to implement advanced detection methods. Navigating compliance with HIPAA, GDPR, and various national regulations often leans towards on-premises setups, while cloud providers offer scalable and budget-friendly options. This regulatory landscape, combined with the surge in digitalization, is acting as a powerful growth driver in both public and private sectors.
3. Expanding Insurance Market and Rising Fraud Incidence
Looking at the global health insurance market, it’s projected to jump from USD 1,835.9 billion in 2023 to USD 3,208.4 billion by 2032, which inevitably leads to a rise in fraudulent claims. This trend highlights the urgent need for strong fraud detection systems. Pharmacy-related fraud is particularly rampant, pushing both payers and providers to invest in solutions that can tackle complex cases. These factors are creating a steady demand for scalable and precise fraud detection software and services.
Request for a sample copy of this report: https://www.imarcgroup.com/healthcare-fraud-detection-market/requestsample
MARKET SEGMENTATION
Component
- Software: Fraud‑detection platforms analyzing insurance and pharmacy claims.
- Services: Third‑party monitoring, risk assessments, analytics outsourcing.
Type
- Descriptive Analytics: Analysis of historical data for trend visualization.
- Predictive Analytics: Real‑time monitoring to flag suspicious claims.
- Prescriptive Analytics: Suggests responses—deny, review, or adjust rules.
Delivery Mode
- On‑premises: Installed on internal servers, preferred for strict compliance like HIPAA/GDPR.
- On‑demand: Cloud‑hosted solutions offering subscription flexibility and reduced upfront costs.
Application
- Insurance Claims Review: Pre‑payment examination of provider claims.
- Payment Integrity: Ensuring insurer payouts are accurate and fraud‑free.
End User
- Private Insurance Payers
- Government Agencies
- Others
Breakup by Region
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa
REGIONAL INSIGHTS
North America is leading the charge in the healthcare fraud detection market, driven by hefty healthcare spending and the complexities of insurance. The swift adoption of electronic health records (EHR) and strict data regulations are pushing for ongoing investments in AI-based detection tools. With a strong focus on both cloud and on-premises models, along with proactive initiatives from payers and the government, the region is well-positioned for continued growth and leadership.
RECENT DEVELOPMENTS & NEWS
Recently, companies have been making strides at the crossroads of AI and identity verification. In September 2024, Microblink unveiled a dedicated Fraud Lab aimed at enhancing tools for identity fraud. Just a month earlier, MediBuddy introduced Sherlock, an AI-powered engine for claims fraud that offers real-time detection. Earlier in March 2024, HealthLock rolled out a platform in the U.S. specifically targeting medical fraud and overbilling through Mastercard. These innovations underscore the industry’s shift towards real-time, AI-integrated solutions that are aware of identity and focused on preventing fraud.
KEY PLAYERS
- CGI Inc.
- Conduent Inc.
- ExlService Holdings Inc.
- Fair Isaac Corporation
- HCL Technologies Limited
- International Business Machines Corporation
- Northrop Grumman Corporation
- RELX Group plc
- SAS Institute Inc.
- UnitedHealth Group
- Wipro Ltd
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5536&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: +1-631-791-1145
